Detalhe da pesquisa
1.
Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006-2022.
J Health Polit Policy Law
; 49(2): 249-268, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801012
2.
Eroding Judicial Deference to the FDA - Consequences for Public Health.
N Engl J Med
; 388(11): 963-966, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912543
3.
Improving the Use of FDA Advisory Committees.
N Engl J Med
; 387(8): 675-677, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984350
4.
Independent Advice on Drug Approvals: an Investigation of EMA Practices.
J Gen Intern Med
; 39(2): 345-347, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904069
5.
Protecting Medicare's Discretion to Say No to Unproven Therapies.
JAMA
; 330(12): 1133-1134, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682556
6.
Inequitable Conduct and Invalidation of Patents Related to Food and Drug Administration-Regulated Products.
JAMA
; 330(21): 2119-2121, 2023 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955942
7.
Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.
JAMA Intern Med
; 183(9): 999-1004, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505487
8.
Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.
JAMA Health Forum
; 4(7): e231718, 2023 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418270
9.
Immigration Law, Public Health, and the Future of Public Charge Policymaking.
J Law Med Ethics
; 50(2): 336-338, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894567
10.
Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs.
Health Aff (Millwood)
; 41(5): 713-721, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500185
11.
Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers.
JAMA Intern Med
; 182(11): 1199-1205, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121676